Developers: | Axena Health |
Date of the premiere of the system: | 2023/06/20 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
The main articles are:
2023: Presentation of the Leva Pelvic Health System
The company Axena Health at the end of June 2023 introduced the Leva Pelvic Health system, designed to treat chronic (fecal incontinence fecal incontinence, FI) in women. American the industry regulator health care (Food and Drug Administration) USA FDA approved the technology for use in 2022.
The Leva System mobile application, along with providing users with assistance in mastering and using the system, together ensure the availability of first-line therapy for this type of chronic disease.
Chronic FI, defined as an uncontrolled fecal unit, is a progressive disease that has a significant negative impact on patients' quality of life. Existing treatment options are limited and few are curative. Although pelvic floor muscle training is the main treatment method, the difficulties associated with properly performing Kegel exercises often make them inaccessible. As a result, women are forced to experience the depression, shame, guilt, frustration and social isolation that often accompany FI. According to statistics, less than 30% of women discuss the symptoms of FI with their attending physician, which means that the number of people suffering from this disease is significantly underestimated.
The Leva system is a medical device for home use, distributed only as prescribed by a doctor. It allows women to train the pelvic floor muscles, helping them improve the strength and coordination of these muscles, leading to reduced symptoms of FI. Combining a small vaginal motion sensor with a smartphone app, the Leva System offers women a simple, non-invasive, drug-free way to do workouts to improve their condition. It is enough to allocate only five minutes a day for classes, while they can be held at home. Tests of the device showed that women using the Leva System for 10 weeks achieved a significant reduction in the severity of the symptoms of FI and, as a result, an increase in quality of life.[1]
The study confirmed the effectiveness of treatment with the Leva System in FI, as well as its effectiveness in urinary incontinence. Since these diseases often accompany each other, a single non-invasive way to treat both diseases can significantly benefit patients and doctors, says Dr. Milena M. Weinstein, assistant professor of gynecology and reproductive biology at Harvard Medical School[2] |